Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Complex Deep Neural Networks for Denoising Ultra-Fast Submillimeter T2*-weighted Imaging and Quantitative Susceptibility Mapping.

European journal of radiology artificial intelligence·2026
Same author

Challenges and future directions for multiple sclerosis after the 2024 McDonald diagnostic criteria.

Nature medicine·2026
Same author

Evaluation of potential serum biomarkers for individuals at risk of multiple sclerosis.

bioRxiv : the preprint server for biology·2026
Same author

Bruton's tyrosine kinase inhibitors: a new class of multiple sclerosis therapeutics.

The Lancet. Neurology·2026
Same author

Application of the 2024 McDonald Criteria in Individuals With Nonspecific Symptoms or Incidental Imaging Findings in a Multicenter Study.

Neurology·2026
Same author

Multi-scale Radiomic Fingerprint: Quantifying Spatial Changes in Biology.

Journal of imaging informatics in medicine·2026

Related Experiment Video

Updated: May 15, 2026

Diffusion Tensor Magnetic Resonance Imaging in Chronic Spinal Cord Compression
07:00

Diffusion Tensor Magnetic Resonance Imaging in Chronic Spinal Cord Compression

Published on: May 7, 2019

Spinal cord quantitative MRI discriminates between disability levels in multiple sclerosis.

Jiwon Oh1, Shiv Saidha, Min Chen

  • 1Department of Neurology, Johns Hopkins University, Baltimore, USA. jioh@jhsph.edu

Neurology
|January 18, 2013
PubMed
Summary

Quantitative MRI measures in the spinal cord can differentiate multiple sclerosis (MS) patients with similar lesion loads but varying disability levels. These advanced imaging techniques offer a more accurate assessment of disease burden than conventional MRI.

More Related Videos

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Related Experiment Videos

Last Updated: May 15, 2026

Diffusion Tensor Magnetic Resonance Imaging in Chronic Spinal Cord Compression
07:00

Diffusion Tensor Magnetic Resonance Imaging in Chronic Spinal Cord Compression

Published on: May 7, 2019

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Area of Science:

  • Neurology
  • Radiology
  • Biomedical Imaging

Background:

  • Multiple sclerosis (MS) often presents a disconnect between clinical symptoms and radiologic findings, especially in the spinal cord (SC).
  • Assessing disability in MS patients with comparable lesion burdens requires sensitive imaging biomarkers.

Purpose of the Study:

  • To evaluate if quantitative diffusion tensor imaging (DTI) and magnetization transfer imaging (MTI) measures in the SC can distinguish MS patients with similar lesion burdens but different disability levels.
  • To explore the utility of advanced MRI techniques in quantifying disease burden in MS.

Main Methods:

  • 124 MS patients underwent 3-T cervical SC MRI.
  • Quantitative DTI (FA, MD, λ(⊥), λ(‖)) and MTI (MTR) measures were calculated in the SC cross-section between C3-C4.
  • Patients were stratified into subgroups based on SC lesion count and disability level. Statistical analyses included t tests and linear regression.

Main Results:

  • Abnormalities in FA, MD, λ(⊥), λ(‖), MTR, and SC cross-sectional area were more pronounced in high-disability subgroups across both low and high lesion count groups.
  • Quantitative MRI measures, particularly FA and MD, showed significant differences between high and low disability subgroups, even in patients with high lesion counts.
  • Advanced MRI metrics revealed clinically relevant differences not apparent with conventional MRI.

Conclusions:

  • Quantitative MRI techniques, including DTI and MTI, provide sensitive measures of SC pathology in MS.
  • These advanced imaging metrics can detect differences in disease burden related to clinical disability, beyond conventional MRI assessments.
  • The findings support the use of quantitative MRI in clinical practice for accurate disease burden assessment and monitoring treatment efficacy in MS.